Bob Simon

Shares of Ibio Inc (NYSE: IBIO) continued higher Tuesday following the 60 Minutes broadcast about ZMapp on CBS by the late Bob Simon. Between February 12 and February 17, the stock rose approximately 125 percent amid news that the company’s plant-based antibody manufacturing technology...

Ibio Inc (NYSE: IBIO) added more than 66 percent this Friday after 60 Minutes announced that Bob Simon’s last story would be on ZMapp, an Ebola drug made from tobacco. IBio helps Mapp Biopharmaceutical, which developed ZMapp, with its plant-based antibody manufacturing technology. Bob...